Grandfield & Dodd LLC Acquires New Position in Danaher Corporation $DHR

Grandfield & Dodd LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 12,620 shares of the conglomerate’s stock, valued at approximately $2,404,000.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. BlackRock Inc. acquired a new position in shares of Danaher during the 2nd quarter valued at about $10,492,520,000. State Street Corp boosted its holdings in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares during the period. Capital International Investors grew its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after purchasing an additional 1,334,221 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Danaher by 11.2% in the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.0%

DHR stock opened at $202.44 on Tuesday. The stock has a market capitalization of $142.31 billion, a P/E ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day moving average of $193.52 and a 200-day moving average of $192.67. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the company earned $0.77 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DHR has been the topic of several analyst reports. TD Cowen lowered their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Stifel Nicolaus cut their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.